Analystreport

Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS) had its price target lowered by analysts at HC Wainwright from $19.00 to $10.00.

Aridis Pharmaceuticals Inc.  (ARDS) 
Last aridis pharmaceuticals inc. earnings: 11/13 04:05 pm Check Earnings Report